On the issue of transparency and reproducibility in nanomedicine
Source abstract
Abstract
Following our call to join in the discussion over the suitability of implementing a reporting checklist for bio–nano papers, the community responds.
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Wilhelm, S. et al. Nat. Rev. Mater. 1, 16014 (2016).10.1038/natrevmats.2016.14 ↗
2. Leong, H. S. et al. Nat. Protoc. 5, 1406–1417 (2010).10.1038/nprot.2010.103 ↗
3. Townson, J. L. et al. J. Am. Chem. Soc. 135, 16030–16033 (2013).10.1021/ja4082414 ↗
4. Dogra, P. et al. Nat. Commun. 9, 4551 (2018).10.1038/s41467-018-06730-z ↗
5. Cho, C.-F., Ablack, A., Leong, H.-S., Zijlstra, A. & Lewis, J. J. Vis. Exp. https://doi.org/10.3791/2808 (2011).10.3791/2808 ↗
6. Durfee, P. N. et al. ACS Nano 10, 8325–8345 (2016).10.1021/acsnano.6b02819 ↗
7. FDA’s Approach to Regulation of Nanotechnology Products (FDA, 2018); https://www.fda.gov/scienceresearch/specialtopics/nanotechnology/ucm301114.htm
8. Swierczewska, M., Crist, R. M. & McNeil, S. E. Methods Mol. Biol. 1682, 3–16 (2018).10.1007/978-1-4939-7352-1_1 ↗
9. Crist, R. M. et al. Integr. Biol. 5, 66–73 (2013).10.1039/c2ib20117h ↗
10. Gioria, S. et al. Nanomedicine https://doi.org/10.2217/nnm-2017-0338 (2018).10.2217/nnm-2017-0338 ↗
11. Caputo, F. et al. J. Control. Release 299, 31–43 (2019).10.1016/j.jconrel.2019.02.030 ↗
12. Prina-Mello, A. in Handbook of Nanomaterials for Cancer Theranostics (ed. Conde, J.) Ch. 17 (Elsevier, 2018).
13. Adiseshaiah, P. P. & Stern, S. T. Methods Mol. Biol. 1682, 241–253 (2018).10.1007/978-1-4939-7352-1_20 ↗
14. Nat. Nanotechnol. 13, 765 (2018).10.1038/s41565-018-0262-4 ↗
15. Faria, M. et al. Nat. Nanotechnol. 13, 777–785 (2018).10.1038/s41565-018-0246-4 ↗
16. Bouwmeester, H. et al. Nanotoxicology 5, 1–11 (2011).10.3109/17435391003775266 ↗
17. Nat. Nanotechnol. 7, 545 (2012).10.1134/S1995078012060110 ↗
18. Pettitt, M. E. & Lead, J. R. Environ. Int. 52, 41–50 (2013).10.1016/j.envint.2012.11.009 ↗
19. Nat. Nanotechnol. 8, 69 (2013).
20. Schrurs, F. & Lison, D. Nat. Nanotechnol. 7, 546–548 (2012).10.1038/nnano.2012.148 ↗
21. Nel, A. E. et al. ACS Nano 9, 5627–5630 (2015).10.1021/acsnano.5b03496 ↗
22. Zhang, H. et al. ACS Nano 6, 4349–4368 (2012).10.1021/nn3010087 ↗
23. Li, R. et al. ACS Nano 8, 1771–1783 (2014).10.1021/nn406166n ↗
24. Li, R. et al. ACS Nano 12, 1390–1402 (2018).10.1021/acsnano.7b07737 ↗
25. Liu, X. et al. J. Clin. Invest. 127, 2007–2018 (2017).10.1172/JCI92284 ↗
26. “Definitions in Biomaterials” Conference Attracts World Experts to Chengdu, China (Society for Biomaterials, 7 January 2018); https://www.biomaterials.org/sites/default/files/docs/2018/biomaterials_definitions_conference_press_release.pdf
27. Clotilde, T. et al. J. Extracell. Vesicles 7, 1535750 (2018).10.1080/20013078.2018.1535750 ↗
28. EV-TRACK Consortium. Nat. Methods 14, 228–232 (2017).10.1038/nmeth.4185 ↗